MBX Biosciences Common Stock Statistics Share Statistics MBX Biosciences Common Stock has 33.42M
shares outstanding. The number of shares has increased by 13.82%
in one year.
Shares Outstanding 33.42M Shares Change (YoY) 13.82% Shares Change (QoQ) 0% Owned by Institutions (%) 99.99% Shares Floating 14.92M Failed to Deliver (FTD) Shares 773 FTD / Avg. Volume 0.21%
Short Selling Information The latest short interest is 4.78M, so 14.31% of the outstanding
shares have been sold short.
Short Interest 4.78M Short % of Shares Out 14.31% Short % of Float 28.77% Short Ratio (days to cover) 13.95
Valuation Ratios The PE ratio is -9.94 and the forward
PE ratio is -4.15.
MBX Biosciences Common Stock's PEG ratio is
-0.12.
PE Ratio -9.94 Forward PE -4.15 PS Ratio 0 Forward PS n/a PB Ratio 2.39 P/FCF Ratio -11.08 PEG Ratio -0.12
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MBX Biosciences Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 24.19,
with a Debt / Equity ratio of 0.
Current Ratio 24.19 Quick Ratio 24.19 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.44M Employee Count 43 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.72, so MBX Biosciences Common Stock's
price volatility has been higher than the market average.
Beta 0.72 52-Week Price Change n/a 50-Day Moving Average 12.24 200-Day Moving Average 13.3 Relative Strength Index (RSI) 47.37 Average Volume (20 Days) 367,791
Income Statement
Revenue n/a Gross Profit n/a Operating Income -68.19M Net Income -61.92M EBITDA -67.95M EBIT -68.19M Earnings Per Share (EPS) -1.85
Full Income Statement Balance Sheet The company has 49.35M in cash and 171K in
debt, giving a net cash position of 49.18M.
Cash & Cash Equivalents 49.35M Total Debt 171K Net Cash 49.18M Retained Earnings -137.5M Total Assets 245.93M Working Capital 233.79M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -54.68M
and capital expenditures -874K, giving a free cash flow of -55.55M.
Operating Cash Flow -54.68M Capital Expenditures -874K Free Cash Flow -55.55M FCF Per Share -1.66
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
